Cart (0 Items)
Your cart is currently empty.
View ProductsHomo sapiens Biosimilar – Anti-MUC5AC mAb – Research Grade
| Size | |
|---|---|
| Brand | |
| Product type | |
| Clonality | |
| Expression system | |
| Applications |
| Product name | Ensituximab Biosimilar - Anti-MUC5AC mAb - Research Grade |
|---|---|
| Source | CAS 1092658-06-4 |
| Species | Chimeric |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Applications | ELISA,WB |
| Aliases /Synonyms | Ensituximab,NOE-102,NPC-1C,MUC5AC,anti-MUC5AC |
| Reference | PX-TA1244 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG1-kappa |
| Clonality | Monoclonal Antibody |
Description of Ensituximab Biosimilar - Anti-MUC5AC mAb - Research Grade
General information on Anti-MUC5AC[Homo sapiens] (Ensituximab) Monoclonal Antibody
Ensituximab has been investigated for the treatment of Pancreatic Cancer and Adult Metastatic Colorectal Cancer.
Related products
Antigen
MUC5AC, C-Fc, recombinant protein
PX-P5842 385€
SIL
Reviews
Il n’y a pas encore d’avis.